ViaTherm Therapeutics

ViaTherm Therapeutics, LLC operates within the therapeutic medical devices sector, focusing on non-invasive pain management solutions. Initially incorporated as ReGear Life Sciences LLC in January 2014, the company is developing and manufacturing deep-heating therapies to alleviate pain and stiffness from chronic conditions, injuries, and aging. The firm's core technology is shortwave diathermy, which uses high-frequency electrical currents to generate therapeutic heat up to four centimeters below the skin's surface. This method is designed to stimulate circulation, decrease muscle spasms, and improve tissue flexibility, offering a more profound and longer-lasting effect than surface-level heat applications like heating pads. The company holds a substantial intellectual property portfolio for its technology.

The company's product line, including the FDA-cleared ViaTherm BOOST, aims to provide an over-the-counter, wearable solution for at-home use. This positions the business to serve a broad market, from individuals with chronic pain and athletes seeking accelerated recovery to physical therapists and long-term care providers. For professionals, the technology can enhance the effectiveness of joint mobilization and stretching protocols. The company is developing a small, rechargeable, and portable wrap called ViVY for the consumer pain management market. ViaTherm Therapeutics is a venture capital-backed, Series A company, having raised approximately $5.2 million to $6.62 million across several funding rounds from investors including Biohealth Innovation, Pittsburgh Life Sciences Greenhouse, and Stonewood Capital Management. The company's first funding round occurred in July 2008.

Michael Thomas has served as the company's CEO. His background includes over 30 years in the healthcare industry, with executive roles at medical device and healthcare services firms. Thomas co-managed a $150 million venture fund at Inova Health System and was CEO of iSonea Limited, a publicly traded respiratory medical device company. He graduated from Cornell University with a degree in Microbiology and has held various sales and marketing positions at companies like Merck and Glaxo Wellcome. The company's leadership also includes Dr. Allistair Abraham, a blood and marrow transplantation specialist who researches sickle cell disease. Dr. Abraham, a graduate of Georgetown University School of Medicine, has been motivated by his own diagnosis of ALS/MND to advance medical technology and patient care.

Keywords: therapeutic devices, pain management, deep heat therapy, shortwave diathermy, medical devices, non-invasive treatment, muscle stiffness, joint mobility, chronic pain relief, wearable medical device, venture capital-backed, Series A, over-the-counter medical device, physical therapy equipment, athletic recovery, home healthcare, pain relief technology, musculoskeletal health, electrotherapy